PT73021B - Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens - Google Patents

Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens

Info

Publication number
PT73021B
PT73021B PT73021A PT7302181A PT73021B PT 73021 B PT73021 B PT 73021B PT 73021 A PT73021 A PT 73021A PT 7302181 A PT7302181 A PT 7302181A PT 73021 B PT73021 B PT 73021B
Authority
PT
Portugal
Prior art keywords
specificyty
polipeptides
mouth disease
viral antigens
foot mouth
Prior art date
Application number
PT73021A
Other languages
English (en)
Other versions
PT73021A (en
Original Assignee
Biogen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Nv filed Critical Biogen Nv
Publication of PT73021A publication Critical patent/PT73021A/pt
Publication of PT73021B publication Critical patent/PT73021B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT73021A 1980-05-12 1981-05-11 Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens PT73021B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8015635 1980-05-12
GB8026661 1980-08-15

Publications (2)

Publication Number Publication Date
PT73021A PT73021A (en) 1981-06-01
PT73021B true PT73021B (en) 1983-10-19

Family

ID=26275483

Family Applications (1)

Application Number Title Priority Date Filing Date
PT73021A PT73021B (en) 1980-05-12 1981-05-11 Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens

Country Status (15)

Country Link
EP (1) EP0040922A1 (pt)
AU (1) AU547096B2 (pt)
BR (1) BR8102922A (pt)
DD (1) DD160279A5 (pt)
DK (1) DK207681A (pt)
ES (2) ES8304204A1 (pt)
GR (1) GR74523B (pt)
IE (1) IE51178B1 (pt)
IL (1) IL62833A (pt)
IN (1) IN156358B (pt)
NO (1) NO811609L (pt)
PL (1) PL231111A1 (pt)
PT (1) PT73021B (pt)
YU (1) YU120581A (pt)
ZW (1) ZW11281A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63126B1 (en) * 1980-06-06 1995-03-22 Biogen Inc Improved vectors and methods for making such vectors and for expressing cloned genes
US4874702A (en) * 1980-09-08 1989-10-17 Biogen, Inc. Vectors and methods for making such vectors and for expressive cloned genes
FR2490239A1 (fr) * 1980-09-18 1982-03-19 Wellcome Found Molecule d'acide desoxyribonucleique comprenant une sequence de nucleotides correspondant a des proteines du virus de la fievre aphteuse, son procede d'obtention et vaccin obtenu
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
GB2103622B (en) * 1981-06-16 1986-01-15 Genentech Inc Production of foot and mouth disease vaccine from microbially expressed antigens
ZA831854B (en) * 1982-03-26 1984-01-25 Biogen Nv Small peptides with the specificity of foot and mouth disease viral antigens
US5230888A (en) * 1982-05-06 1993-07-27 Massachusetts Institute Of Technology Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
US4751083A (en) * 1982-05-06 1988-06-14 Massachusetts Institute Of Technology Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
EP0105481A1 (en) * 1982-09-30 1984-04-18 The Wellcome Foundation Limited Novel antigens and vaccines containing them
WO1984003506A1 (en) * 1983-03-08 1984-09-13 Commw Serum Lab Commission Antigenically active amino acid sequences
AU573574B2 (en) * 1983-03-08 1988-06-16 Chiron Mimotopes Pty Ltd Immunogenic deteminants of foot and mouth disease virus
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
BE901119A (fr) * 1984-11-23 1985-03-15 Wallone Region Procede de preparation de plasmides vecteurs capables de transformer un hote bacterien escherichia coli et d'y promouvoir et controler l'expression d'un adn heterologue.
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4732971A (en) * 1985-06-03 1988-03-22 Eli Lilly And Company Synthetic vaccines for foot and mouth disease
US6479787B1 (en) 1999-10-05 2002-11-12 Rexam Ab Laser unit and method for engraving articles to be included in cans

Also Published As

Publication number Publication date
IL62833A (en) 1984-12-31
ES511491A0 (es) 1983-06-16
AU7045581A (en) 1981-12-10
IL62833A0 (en) 1981-07-31
YU120581A (en) 1984-04-30
DD160279A5 (de) 1983-05-25
ZW11281A1 (en) 1982-04-21
BR8102922A (pt) 1982-02-02
EP0040922A1 (en) 1981-12-02
DK207681A (da) 1981-11-13
NO811609L (no) 1981-11-13
IE811049L (en) 1981-11-12
IN156358B (pt) 1985-07-06
ES8304204A1 (es) 1983-02-16
AU547096B2 (en) 1985-10-03
PL231111A1 (en) 1983-07-18
ES502089A0 (es) 1982-12-16
GR74523B (pt) 1984-06-29
PT73021A (en) 1981-06-01
IE51178B1 (en) 1986-10-29
ES8307298A1 (es) 1983-06-16

Similar Documents

Publication Publication Date Title
PT73021B (en) Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens
PT72322A (en) Dna sequences recombinant dna molecules and processes for producing human interferon-like polipeptidses for pro- ducing human "interferon"-like polypees ptides
YU140380A (en) Process for obtaining dna fragment of hepatitis b virus
PH25120A (en) Replicable expression vehicle and process of preparation thereof
PT76451B (en) Process for preparing small peptides with the specificity of foot and mouth disease viral antigens and of veterinary compositions containing the same
BE880670A (fr) Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant
HK1003794A1 (en) Hepatitis b surface antigen formed by recombinant dna techniques vaccines diagnostic cell lines and methods of forming same
PT76726B (en) Process for producing the a and b subunits of cholera toxin and related dna sequences and recombinant dna molecules
OA09625A (en) DNA sequences recombinant DNA molecules and processes for producing soluble T4 proteins
DE3583564D1 (de) Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
IL89992A0 (en) Expression of human serum albumin in methylotrophic yeasts
PL279426A1 (en) Method of intensifying generation of antigenic hbv particles containing essentially s and pre s2 proteins
EP0264819A3 (en) Variant aequorin genes and process for producing variant aequorin proteins
IL69514A0 (en) Recombinant dna molecules,process for their production,their use for production of hepatitis b surface antigen(hbsag)and pharmaceutical compositions containing this hbsag
GB2079288B (en) Dna sequences recombinat dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens
GB2068970B (en) Recombinant dna technique for the preparation of a protein resembling human interferon
ZA863789B (en) Process for the in vitro immunization of human splenocytes against tumor associated antigens
EP0154587A3 (en) Fragments of dna which encode peptides capable of inducing in vivo the synthesis of anti-hepatitis a virus antibodies
ZA813110B (en) Dna sequences, recombinant dna molecules and processes for producing polypedtides with the specificity of foot and mouth disease viral antigens
IL61994A0 (en) Recombinatn dna technique for the preparation of a protein resembling human interferon
GB2064322B (en) Process for purifying particles of biological origin particularly the surface antigen of the virus of hepatitis b (aghbs)
IL77830A (en) Dna sequences, recombinant dna molecules and processes for producing human b-interferon
HRP940049B1 (en) Process for the preparation of recombinant dna molecules
IE861358L (en) Process for the in vitro immunization of human splenocytes¹against tumor associated antigens
HU9802975D0 (en) Recombinant avipox viruses, the culture of cells infected by these viruses, vaccines for poultry, transfer sequences for production of viruses and plas mids containing of these sequences and process for producing thereof and use of viruses as vectors